A γ-tocopherol-rich mixture of tocopherols inhibits chemically induced lung tumorigenesis in A/J mice and xenograft tumor growth

Carcinogenesis

Volumn 31, Issue 4, 2010, Pages 687-694

  Lu, Gang ^a   Xiao, Hang ^a,b   Li, Guang Xun ^a   Picinich, Sonia C ^a,c   Chen, Yu Kuo ^a   Liu, Anna ^a   Lee, Mao Jung ^a   Loy, Shea ^a   Yang, Chung S ^a  

^a RUTGERS UNIVERSITY   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; ALPHA TOCOPHEROL; BENZO[A]PYRENE; BETA TOCOPHEROL; DELTA TOCOPHEROL; GAMMA TOCOPHEROL; HISTONE H2AX; 3-NITROTYROSINE; 4-(N-METHYL-N-NITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE; 8 HYDROXYDEOXYGUANOSINE; 8-HYDROXY-2'-DEOXYGUANOSINE; ANTIOXIDANT; DEOXYGUANOSINE; DRUG DERIVATIVE; H2AFX PROTEIN, HUMAN; HISTONE; LEUKOTRIENE B4; NITROSAMINE; PROSTAGLANDIN E2; TYROSINE;

A J MOUSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MIXTURE; FEMALE; HUMAN; HUMAN CELL; LUNG CANCER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR VOLUME; TUMOR XENOGRAFT; VITAMIN SUPPLEMENTATION; ANIMAL; BLOOD; CELL PROLIFERATION; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; DRUG SCREENING; LUNG TUMOR; NEOVASCULARIZATION (PATHOLOGY); TUMOR CELL LINE; VASCULARIZATION;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; BENZO(A)PYRENE; CELL LINE, TUMOR; CELL PROLIFERATION; DEOXYGUANOSINE; DINOPROSTONE; FEMALE; GAMMA-TOCOPHEROL; HISTONES; LEUKOTRIENE B4; LUNG NEOPLASMS; MICE; NEOVASCULARIZATION, PATHOLOGIC; NITROSAMINES; TYROSINE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77950886851     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp332     Document Type: Article

References (50)

1. Jemal,A. et al. (2008) Cancer statistics, 2008. CA Cancer J. Clin., 58, 71-96.
2. Ju,J. et al. (2009) A gamma-tocopherol-rich mixture of tocopherols inhibits colon inflammation and carcinogenesis in azoxymethane and dextran sulfate sodium-treated mice. Cancer Prev. Res. (Phila Pa), 2, 143-152.
3. Dietrich,M. et al. (2006) Does gamma-tocopherol play a role in the primary prevention of heart disease and cancer? A review. J. Am. Coll. Nutr., 25, 292-299.
4. Hensley,K. et al. (2004) New perspectives on vitamin E: gamma-tocopherol and carboxyelthylhydroxychroman metabolites in biology and medicine. Free Radic. Biol. Med., 36, 1-15.
5. Traber,M.G. (2006) Vitamin E. Modern Nutrition in Health and Disease, 10th ed. Lippincott Williams and Wilkins Baltimore, MD, pp. 396-411.
6. Traber,M.G. et al. (2007) Vitamin E, antioxidant and nothing more. Free Radic. Biol. Med., 43, 4-15.
7. Eitenmiller,T. et al. (2004) Vitamin E: Food Chemistry, Composition, and Analysis. Marcel Dekker, Inc., New York, NY.
8. Ju,J. et al. (2009) Cancer preventive activities of tocopherols and tocotrienols. Carcinogenesis, Advanced access published September 11, 2009.
9. Lippman,S.M. et al. (2009) Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA., 301, 39-51.
10. Gaziano,J.M. et al. (2009) Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA., 301, 52-62.
11. Campbell,S. et al. (2003) Development of gamma (gamma)-tocopherol as a colorectal cancer chemopreventive agent. Crit. Rev. Oncol. Hematol., 47, 249-259.
12. Reiter,E. et al. (2007) Anti-inflammatory properties of alphaand gammatocopherol. Mol. Aspects Med., 28, 668-691.
13. Newmark,H.L. et al. (2006) Mixed tocopherols inhibit azoxymethaneinduced aberrant crypt foci in rats. Nutr. Cancer, 56, 82-85.
14. Suh,N. et al. (2007) Mixed tocopherols inhibit N-methyl-N-nitrosoureainduced mammary tumor growth in rats. Nutr. Cancer, 59, 76-81.
15. Lee,H.J. et al. (2009) Mixed tocopherols prevent mammary tumorigenesis by inhibiting estrogen action and activating PPAR-g. Clin. Cancer Res, 15, 4242-4249.
16. Barve,A. et al. (2009) Gamma-tocopherol-enriched mixed tocopherol diet inhibits prostate carcinogenesis in TRAMP mice. Int. J. Cancer, 124, 1693-1699.
17. Comstock,G.W. et al. (1997) The risk of developing lung cancer associated with antioxidants in the blood: ascorbic acid, carotenoids, alpha-tocopherol, selenium, and total peroxyl radical absorbing capacity. Cancer Epidemiol. Biomarkers Prev., 6, 907-916.
18. Goodman,G.E. et al. (2003) The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial. Cancer Epidemiol. Biomarkers Prev., 12, 518-526.
19. Menkes,M.S. et al. (1986) Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer. N. Engl. J. Med., 315, 1250-1254.
20. Ratnasinghe,D. et al. (2000) Serum tocopherols, selenium and lung cancer risk among tin miners in China. Cancer Causes Control, 11, 129-135.
21. Shibata,A. et al. (1992) Intake of vegetables, fruits, beta-carotene, vitamin C and vitamin supplements and cancer incidence among the elderly: a prospective study. Br.J.Cancer, 66, 673-679.
22. Woodson,K. et al. (1999) Association between alcohol and lung cancer in the alpha-tocopherol, beta-carotene cancer prevention study in Finland. Cancer Causes Control, 10, 219-226.
23. Yong,L.C. et al. (1997) Intake of vitamins E, C, and A and risk of lung cancer. The NHANES I epidemiologic followup study. First National Health and Nutrition Examination Survey. Am. J. Epidemiol., 146, 231-243.
24. Albanes,D. et al. (1996) Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J. Natl Cancer Inst., 88, 1560-1570.
25. Ogasawara,M. et al. (2007) Differential effects of antioxidants on the in vitro invasion, growth and lung metastasis of murine colon cancer cells. Biol. Pharm. Bull., 30, 200-204.
26. Lambert,J.D. et al. (2009) Inhibition of lung cancer growth in mice by dietary mixed tocopherols. Mol. Nutr. Food Res, 53, 1030-1035.
27. Belinsky,S.A. et al. (1992) Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-1(3-pyridyl)-1-butanone in the A/J mouse. Cancer Res., 52, 3164-3173.
28. Yang,G. et al. (1997) Characterization of early pulmonary hyperproliferation and tumor progression and their inhibition by black tea in a 4(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model with A/J mice. Cancer Res., 57, 1889-1894.
29. Hecht,S.S. (1998) Biochemistry, biology, and carcinogenicity of tobaccospecific N-nitrosamines. Chem. Res. Toxicol., 11, 559-603.
30. Szatrowski,T.P. et al. (1991) Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res., 51, 794-798.
31. Kawanishi,S. et al. (2006) Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis. Biol. Chem., 387, 365-372.
32. Pani,G. et al. (2002) Determination of intracellular reactive oxygen species as function of cell density. Methods Enzymol., 352, 91-100.
33. Colavitti,R. et al. (2002) Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. J. Biol. Chem., 277, 3101-3108.
34. Choi,M.H. et al. (2005) Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature, 435, 347-353.
35. Rhyu,D.Y. et al. (2005) Role of reactive oxygen species in TGF-beta1induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J. Am. Soc. Nephrol., 16, 667-675.
36. Arakaki,N. et al. (1999) Involvement of oxidative stress in tumor cytotoxic activity of hepatocyte growth factor/scatter factor. J. Biol. Chem., 274, 13541-13546.
37. Boonstra,J. et al. (2004) Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene, 337, 1-13.
38. Behrend,L. et al. (2003) Reactive oxygen species in oncogenic transformation. Biochem. Soc. Trans., 31, (pt. 6),1441-1444.
39. Wu,W.S. (2006) The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev., 25, 695-705.
40. Ushio-Fukai,M. et al. (2004) Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol. Cell Biochem., 264, 85-97.
41. Ushio-Fukai,M. et al. (2008) Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett., 266, 37-52.
42. Devaraj,S. et al. (2008) Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome. Free Radic. Biol. Med., 44, 1203-1208.
43. Jiang,Q. et al. (2000) gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc. Natl Acad. Sci. USA, 97, 11494-11499.
44. Campbell,S.E. et al. (2003) Gamma (gamma) tocopherol upregulates peroxisome proliferator activated receptor (PPAR) gamma (gamma) expression in SW 480 human colon cancer cell lines. BMC Cancer, 3, 25.
45. Gysin,R. et al. (2002) Gamma-tocopherol inhibits human cancer cell cycle progression and cell proliferation by down-regulation of cyclins. FASEB J., 16, 1952-1954.
46. Samandari,E. et al. (2006) The effect of gamma-tocopherol on proliferation, integrin expression, adhesion, and migration of human glioma cells. Biochem. Biophys. Res. Commun., 342, 1329-1333.
47. Jiang,Q. et al. (2004) Gamma-tocopherol induces apoptosis in androgenresponsive LNCaP prostate cancer cells via caspase-dependent and independent mechanisms. Ann. N. Y. Acad. Sci., 1031, 399-400.
48. Jiang,Q. et al. (2003) Gamma-tocopherol, but not alpha-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats. FASEB J., 17, 816-822.
49. O'Leary,K.A. et al. (2004) Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription. Mutat. Res., 551, 245-254.
50. Mahabir,S. et al. (2008) Dietary alpha-, beta-, gammaand delta-tocopherols in lung cancer risk. Int. J. Cancer, 123, 1173-1180.